Exemption number (b)(4) ermits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.Based on the information provided, the reported difficulties appear to be due to case circumstances.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported that the procedure was to treat a moderately tortuous, heavily calcified internal carotid de novo artery that was 80% stenosed.A 7-10/40 mm acculink carotid stent delivery system was advanced to the lesion.During implantation of the stent, there was poor visibility of the stent.It was not easy to confirm if the stent had been fully deployed/implanted until final contrast was performed.The lesion was standard post-dilated with a 5 x 20 mm non-abbott balloon.The final result was good.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|